Priority Technology (PRTH) closed the last trading session at $7.65, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.6 indicates a 64.7% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $2.3. While the lowest estimate of $10.00 indicates a 30.7% increase from the current price level, the most optimistic analyst ...

Mission Produce, Inc. (AVO) closed the last trading session at $11.76, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.33 indicates a 47.4% upside potential.The average comprises three short-term price targets ranging from a low of $17.00 to a high of $18.00, with a standard deviation of $0.58. While the lowest estimate indicates an increase of 44.6% from the curre ...

MBX Biosciences, Inc. (MBX) closed the last trading session at $15.86, gaining 54.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $60.29 indicates a 280.1% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $18.94. While the lowest estimate of $30.00 indicates an 89.2% increase from the current price level, the most optimisti ...

Core Viewpoint - UBS has set a price target of $255 for Assurant, indicating a potential upside of approximately 17.9% from the current stock price of $216.29 [1] Group 1: Financial Performance - Assurant is set to announce its third-quarter financial results on November 4, 2025, after market close, with a conference call scheduled for the following morning [2] - The upcoming financial results are expected to influence the stock's performance and investor sentiment [2] Group 2: Stock Performance - Currently, Assurant's stock price is $216.29, reflecting a decrease of $5.40 or approximately -2.44% [3] - The stock has traded between $216.21 and $223.65 today, with a yearly high of $230.55 and a low of $174.97, indicating volatility [3] Group 3: Market Capitalization - Assurant's market capitalization is approximately $10.91 billion, with a trading volume of 365,113 shares on the NYSE, reflecting the company's size and investor interest [4] - The upcoming financial results could impact the market capitalization and trading volume depending on the company's performance [4]

Lakeland Industries (LAKE) closed the last trading session at $14.8, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.25 indicates a 63.9% upside potential.The average comprises four short-term price targets ranging from a low of $20.00 to a high of $27.00, with a standard deviation of $3.1. While the lowest estimate indicates an increase of 35.1% from the current p ...

Perpetua Resources Corp. (PPTA) closed the last trading session at $20.23, gaining 8.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.73 indicates a 27.2% upside potential.The average comprises five short-term price targets ranging from a low of $21.00 to a high of $30.00, with a standard deviation of $3.68. While the lowest estimate indicates an increase of 3.8% from the cur ...

Core Insights - Harrow, Inc. has garnered investor attention with a recent price target of $70 set by Thomas Flaten from Lake Street, indicating a potential increase of approximately 48.62% from the current stock price of $47.10 [1] - The company held its Analyst/Investor Day on September 26, 2025, where key executives provided insights into its strategic direction and financial outlook, attended by analysts from notable firms [2] - The stock price of HROW has recently increased by $0.95, or 2.06%, with a trading range on the same day between $46.29 and $50.72, reflecting significant volatility over the past year [3] - Harrow's market capitalization stands at approximately $1.74 billion, with a trading volume of 1,326,594 shares, indicating strong investor interest and potential upside [4]

Core Viewpoint - US Gold Corp (USAU) has shown a significant price increase of 13.3% over the past four weeks, with a mean price target of $19.5 indicating a potential upside of 29% from the current price of $15.12 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $4.27, where the lowest estimate is $15.00 (indicating a 0.8% decline) and the highest estimate is $23.50 (indicating a 55.4% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - There is a strong consensus among analysts regarding the company's ability to report better earnings, with a 17.8% increase in the Zacks Consensus Estimate for the current year [11][12] - USAU holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to potential biases and inflated targets set by analysts [3][8][10]

Group 1 - Photronics (PLAB) shares have increased by 11.1% over the past four weeks, closing at $24.73, with a mean price target of $31.65 indicating a potential upside of 28% [1] - The mean estimate includes three short-term price targets with a standard deviation of $1.51, where the lowest estimate suggests a 21.3% increase and the highest indicates a 33.2% surge [2] - Analysts show a strong consensus that PLAB will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for PLAB has increased by 7.7% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - PLAB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for price movement [14]

Shares of MBX Biosciences, Inc. (MBX) have gained 44% over the past four weeks to close the last trading session at $20, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37.71 indicates a potential upside of 88.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $4.23. While the lowest estimate of $30.00 indicates a 50% increase from the cu ...